U.S. expands Latin America drug fight with joint operation in Ecuador
Source: SeekingAlpha
2026-03-04 19:17:34 ET
More news and analysis
- Lerøy Seafood Group ASA (LYSFY) Analyst/Investor Day Transcript
- Niagen Bioscience, Inc. (NAGE) Q4 2025 Earnings Call Transcript
- Bandwidth Inc. (BAND) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
- Niagen Bioscience targets 10–15% revenue growth for 2026 while expanding injectable product line
- Sight Sciences outlines $82M–$88M 2026 revenue target while expanding interventional dry eye strategy
Read the full article on Seeking Alpha
For further details see:
U.S. expands Latin America drug fight with joint operation in Ecuador
Niagen Bioscience Inc.
NASDAQ: NAGE
NAGE Trading
4.8% G/L:
$5.235 Last:
988,442 Volume:
$4.925 Open:
NAGE Latest News
NAGE Stock Data
$408,607,432
52,743,877
N/A
66
N/A
Biotechnology & Life Sciences
Healthcare
US
Los Angeles
